Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	21.77	-13.89	-17.76
Graham Fair Price	41.42	0.66	0.47
PEG	-43.33	-0.02	0.04
Price/Book	15.00	0.08	0.07
Price/Cash Flow	42.73	-9.07	-15.84
Prices/Earnings	42.49	-2.09	-3.64
Price/Sales	-42.50	14.23	24.75
Price/FCF	42.73	-9.07	-15.84
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-51.64	0.35	0.71
Operating Margin	2.31	-1.27	-1.30
ROA	-99.97	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-99.97
ROIC	< 0.005	< 0.005	-44.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.33	1.84	-81.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.69	-0.95	38.28
EPS QOQ	0.97	-0.99	1.47
FCF QOQ	0.48	-1.01	107.93
Revenue QOQ	1.05	1.00	-4.33
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5140.21	1122.25	-78.17
Days Sales Outstanding (DSO)	380.98	1950.34	411.93
Inventory Turnover	0.02	0.08	358.03
Debt/Capitalization	< 0.005	< 0.005	32.79
Quick Ratio	0.32	1.41	336.96
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.41	1.41	< 0.005
Cash	0.03	0.03	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	< 0.005	-0.01	-100.82
Revenue	< 0.005	< 0.005	100.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.16	3.16	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.81	1.96	-48.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating